These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 18485090)
21. Serious venous thromboembolism, heterozygous factor V Leiden and prothrombin G20210A mutations in a patient with Klinefelter syndrome and type 2 diabetes. Ayli M; Ertek S Intern Med; 2009; 48(18):1681-5. PubMed ID: 19755774 [TBL] [Abstract][Full Text] [Related]
22. Severe bleeding in a woman heterozygous for the fibrinogen gammaR275C mutation. Rein CM; Anderson BL; Ballard MM; Domes CM; Johnston JM; Madsen RJ; Wolper KK; Terker AS; Strother JM; Deloughery TG; Farrell DH Blood Coagul Fibrinolysis; 2010 Jul; 21(5):494-7. PubMed ID: 20386430 [TBL] [Abstract][Full Text] [Related]
23. Confirmation of mendelian properties of heterodimeric fibrinogen molecules in a heterozygotic dysfibrinogenemia, "fibrinogen Amarillo," using gprphoresis to differentiate semifibrin molecules from fibrinogen and fibrin. Shainoff JR; Ratnoff OD; Smejkal GB; DiBello PM; Welches WR; Lill H; Mitkevich OV; Periman P Thromb Res; 2001 Jan; 101(2):91-9. PubMed ID: 11342210 [TBL] [Abstract][Full Text] [Related]
24. Fibrinogen Bern I: substitution gamma 337 Asn-->Lys is responsible for defective fibrin monomer polymerization. Steinmann C; Reber P; Jungo M; Lämmle B; Heinemann G; Wermuth B; Furlan M Blood; 1993 Oct; 82(7):2104-8. PubMed ID: 8400260 [TBL] [Abstract][Full Text] [Related]
25. Fibrinogen Geneva, a new case of A alpha 16 Arg----Cys dysfibrinogenaemia. Furlan M; Bögli C; Hofer A; Bouvier CA; de Moerloose P Blood Coagul Fibrinolysis; 1990 Jun; 1(2):139-43. PubMed ID: 2130925 [TBL] [Abstract][Full Text] [Related]
27. Fibrinogen kaiserslautern III: a new case of congenital dysfibrinogenemia with aalpha 16 arg-->cys substitution. Loreth RM; Meyer M; Albert FW Haemostasis; 2001; 31(1):12-7. PubMed ID: 11408744 [TBL] [Abstract][Full Text] [Related]
28. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis. Stucki B; Schmutz P; Schmid L; Haeberli A; Lämmle B; Furlan M Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005 [TBL] [Abstract][Full Text] [Related]
29. Fibrinogen Šumperk II: dysfibrinogenemia in an individual with two coding mutations. Kotlín R; Suttnar J; Cápová I; Hrachovinová I; Urbánková M; Dyr JE Am J Hematol; 2012 May; 87(5):555-7. PubMed ID: 22407772 [TBL] [Abstract][Full Text] [Related]
30. [Factor XIII-A subunit Val34Leu polymorphism and risk of venous thromboembolism in young adults]. Demyanenko AV; Kapustin SI; Soroka VV; Chechulov PV Angiol Sosud Khir; 2015; 21(2):21-5. PubMed ID: 26035561 [TBL] [Abstract][Full Text] [Related]
31. The mutation in fibrinogen Bicêtre II (gamma Asn308-->Lys) does not affect the binding of t-PA and plasminogen to fibrin. Grailhe P; Boyer-Neumann C; Haverkate F; Grimbergen J; Larrieu MJ; Anglés-Cano E Blood Coagul Fibrinolysis; 1993 Oct; 4(5):679-87. PubMed ID: 8292717 [TBL] [Abstract][Full Text] [Related]
32. Fibrinogen Milano XIII (Aalpha 19 Arg-->Gly): a dysfunctional variant with an amino acid substitution in the N-terminal polymerization site. Bolliger-Stucki B; Bucciarelli P; Lämmle B; Furlan M Thromb Res; 1999 Dec; 96(5):399-405. PubMed ID: 10605955 [No Abstract] [Full Text] [Related]
33. Dysfibrinogenemia (fibrinogen Wilmington) due to a novel Aalpha chain truncation causing decreased plasma expression and impaired fibrin polymerisation. Brennan SO; Mosesson MW; Lowen R; Frantz C Thromb Haemost; 2006 Jul; 96(1):88-9. PubMed ID: 16807657 [No Abstract] [Full Text] [Related]
34. Two novel fibrinogen variants found in patients with pulmonary embolism and their families. Hanss MM; Ffrench PO; Mornex JF; Chabuet M; Biot F; De Mazancourt P; Dechavanne M J Thromb Haemost; 2003 Jun; 1(6):1251-7. PubMed ID: 12871327 [TBL] [Abstract][Full Text] [Related]
35. Fibrinogen Saint-Germain II: hypofibrinogenemia due to heterozygous gamma N345S mutation. de Raucourt E; de Mazancourt P; Maghzal GJ; Brennan SO; Mosesson MW Thromb Haemost; 2005 Nov; 94(5):965-8. PubMed ID: 16363237 [TBL] [Abstract][Full Text] [Related]
36. Severe hypodysfibrinogenemia in compound heterozygotes of the fibrinogen AalphaIVS4 + 1G>T mutation and an AalphaGln328 truncation (fibrinogen Keokuk). Lefebvre P; Velasco PT; Dear A; Lounes KC; Lord ST; Brennan SO; Green D; Lorand L Blood; 2004 Apr; 103(7):2571-6. PubMed ID: 14615374 [TBL] [Abstract][Full Text] [Related]
37. D-dimer cut-off points and risk of venous thromboembolism in adult hospitalized patients with COVID-19. Choi JJ; Wehmeyer GT; Li HA; Alshak MN; Nahid M; Rajan M; Liu B; Schatoff EM; Elahjji R; Abdelghany Y; D'Angelo D; Crossman D; Evans AT; Steel P; Pinheiro LC; Goyal P; Safford MM; Mints G; DeSancho MT Thromb Res; 2020 Dec; 196():318-321. PubMed ID: 32977130 [No Abstract] [Full Text] [Related]
38. Gamma371 Thr-->Ile substitution in the fibrinogen gammaD domain causes hypofibrinogenaemia. Brennan SO; Wyatt JM; Fellowes AP; Dlott JS; Triplett DA; George PM Biochim Biophys Acta; 2001 Dec; 1550(2):183-8. PubMed ID: 11755207 [TBL] [Abstract][Full Text] [Related]
39. Fibrinogens Bern IV, Bern V and Milano XI: three dysfunctional variants with amino acid substitutions in the thrombin cleavage site of the Aalpha-chain. Stucki B; Zenhäusern R; Biedermann B; Baudo F; Redaelli R; Lämmle B; Furlan M Blood Coagul Fibrinolysis; 1999 Mar; 10(2):93-9. PubMed ID: 10192658 [TBL] [Abstract][Full Text] [Related]
40. Heterozygous abnormal fibrinogen Osaka III with the replacement of gamma arginine-275 by histidine has an apparently higher molecular weight gamma-chain variant. Yoshida N; Imaoka S; Hirata H; Matsuda M; Asakura S Thromb Haemost; 1992 Nov; 68(5):534-8. PubMed ID: 1455400 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]